Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Electrical muscle stimulation therapy: Multi channel (8 channels) electrical stimulator will be used to deliver Russian current of 2500 Hz of motor level intensity with 10 seconds of st
Sponsors
Vishwajeet Trivedi
Eligibility
Inclusion criteria
Inclusion criteria: Type 2 diabetic patients of 45 to 65 years. Subjects with fasting blood glucose level 100 mg / dl Both males and females with type 2 diabetes will be recruited Subject should not have any major systemic or diabetic complication. Subjects who are on oral hypoglycemic drugs and not on insulin administration. Subjects with low activity level as per IPAQ criteria. (Booth,2000) Cooperative in nature and willing to participate in the study.
Exclusion criteria
Exclusion criteria: Subjects with type 1 Diabetes mellitus. Using insulin/injections of any kind Pregnant women Physically active subjects. Uncontrolled and fluctuating hypertension and blood glucose level Previous myocardial infarction Any other condition or history that might increase the risk to the individual or interfere with the study or the evaluation of data. Cardiac arrhythmias Non cooperative and unwilling subjects. Use of metal implants, cardiac pacemakers or any other electrical device that are contraindicated for electrical stimulation. Subjects who undergone any major surgical intervention. Skin condition that may interfere with the delivery of the electrical stimulation. Addicted to alcohol, smoking or drugs that interferes with the neuromuscular system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Glucose level, HbA1c, Basic Lipid profileTimepoint: At start of intervention, the end of 3-month intervention & after 3 months of intervention for follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Body weight, Heart rate, Blood Pressure, Body Composition, skin fold, Activity level, Functional Exercise Capacity, Adverse Effects, Changes in medication dose /use, food profile.Timepoint: At start of intervention, the end of 3-month intervention & after 3 months of intervention for follow-up | — |
Countries
India
Contacts
Public ContactDr Neelima Mishra
GD Goenka University
Outcome results
None listed